Compare EW & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EW | RELX |
|---|---|---|
| Founded | 1958 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | 37600 |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.9B | 56.1B |
| IPO Year | 1999 | N/A |
| Metric | EW | RELX |
|---|---|---|
| Price | $83.40 | $37.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 1 |
| Target Price | ★ $96.37 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 2.8M |
| Earning Date | 04-23-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $6,067,600,000.00 | N/A |
| Revenue This Year | $13.39 | $8.72 |
| Revenue Next Year | $9.81 | $6.41 |
| P/E Ratio | $125.82 | ★ $20.27 |
| Revenue Growth | ★ 11.55 | N/A |
| 52 Week Low | $72.30 | $27.57 |
| 52 Week High | $96.29 | $52.23 |
| Indicator | EW | RELX |
|---|---|---|
| Relative Strength Index (RSI) | 35.80 | 72.18 |
| Support Level | $82.02 | $35.53 |
| Resistance Level | $86.49 | $37.78 |
| Average True Range (ATR) | 2.39 | 0.82 |
| MACD | -0.92 | 0.45 |
| Stochastic Oscillator | 17.78 | 96.04 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
RELX is a developer of information-based analytics and decision tools designed to support research, risk assessment, legal work, and business operations. The company offers data analytics, scientific and technical information resources, legal research tools, and event management platforms. This enables professionals, researchers, legal teams, and businesses to make informed decisions and improve operational efficiency.